Your browser doesn't support javascript.
loading
Decadal Analysis of Age-Adjusted Mortality Rates for Acute and Chronic Kidney Disease in Brazil, 2000-2021.
Hauwanga, Wilhelmina N; Alphonse, Berley; Akram, Ifrah; Djeagou, Albine; Lima Pessôa, Bruno; McBenedict, Billy.
Affiliation
  • Hauwanga WN; Family Medicine, Federal University of the State of Rio de Janeiro, Rio de Janeiro, BRA.
  • Alphonse B; Neurosurgery, Fluminense Federal University, Niterói, BRA.
  • Akram I; Neurosurgery, Fluminense Federal University, Niterói, BRA.
  • Djeagou A; Neurosurgery, Fluminense Federal University, Niterói, BRA.
  • Lima Pessôa B; Neurosurgery, Fluminense Federal University, Niterói, BRA.
  • McBenedict B; Neurosurgery, Fluminense Federal University, Niterói, BRA.
Cureus ; 16(6): e61657, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38966439
ABSTRACT
Introduction Renal failure, comprising acute kidney injury (AKI) and chronic kidney disease (CKD), involves a decline or loss of kidney function. AKI is sudden and reversible, with a rapid decline in function over hours to days, while CKD involves persistent abnormalities lasting at least three months. Developing countries are seeing a rise in AKI cases, especially in critically ill patients. Globally, there's a growing occurrence and mortality rate linked to CKD. Methods The study used a retrospective cross-sectional design to analyze AKI and CKD mortality rates in Brazil from 2019 to 2022. Data on population and demographics, including sex and age, were obtained from the Brazilian Institute of Geography and Statistics. Mortality data for kidney diseases were sourced from the Brazilian Hospital Information System. The analysis utilized the Joinpoint Regression Program to calculate average annual percentage changes (AAPCs) and their respective 95% confidence intervals. Weighted Bayesian information criterion was used to determine the significance levels and identify the best-fitting combination of line segments and joinpoints. Results The study findings revealed a significant rise in AKI mortality rates for both males and females, from 2008 to 2021 (APC = 3.16; CI 2.29 to 5.93), with higher mortality rates recorded among males compared to women over the entire study period. Analyses according to age groups showed that males between the ages 40 to 49 experienced the most rapid increase in mortality during the 2019 - 2021 period (APC = 35.41; CI 16.72 to 46.57); meanwhile, the most rapid increase in mortality for females was observed from 2019 to 2021, and this was among those aged 30 to 39 (APC = 40.33; CI = 6.48 to 59.78). Furthermore, there was an observable upward trend in mortality related to CKD (APC = 0.70; CI 0.41 to 1.01), with males consistently having higher mortality rates throughout the entire study period. The elderly population, both males and females, experienced the most rapid increase in CKD-related mortality, with AAPC values of 2.32 (CI 1.82 to 2.89) for males and 1.62 (CI 1.08 to 2.10) for females. Conclusion We observed a consistent increase in mortality rates from acute kidney diseases for both males and females since 2008, with males experiencing higher mortality rates overall. The study highlighted the need for further research to understand the underlying factors contributing to these trends. Additionally, interventions targeting modifiable risk factors and improving access to healthcare could help reduce mortality related to renal failure.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Country/Region as subject: America do sul / Brasil Language: En Journal: Cureus Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Country/Region as subject: America do sul / Brasil Language: En Journal: Cureus Year: 2024 Document type: Article